Fluid management in perioperative period
A Special Edition by
Anesthesiology – Open Journal (AOJ)
Submissions deadline: January, 2018 (Article Processing Charges for Research articles is $679 USD and for short communications will be the $379 USD. For more details
Accepted Date: March, 2018.
Release Date: April, 2018 (Accepted papers will be published online immediately).
Special Edition Editors
Rakesh Garg, MD, DNB, PGCCHM, MNAMS, CCEPC
Fellowship in Palliative Medicine
Associate Professor of Anaesthesiology
Intensive Care, Pain and Palliative Care
Dr BRAIRCH, All India Institute of Medical Sciences, New Delhi-110029, India
Associate Guest Editor
Dr. Uma Hariharan, MBBS, DNB, PGDHM
Fellowship Onco-Anesthesia and Advanced Regional Anesthesia.
Dr Ram Manohar Lohia Hospital
Post Graduate Institute of Medical Education and Research
Central Health Services, Teaching Cadre
New Delhi (Central Health Services), Govt. of India
Introduction of Special Edition
Intravenous fluids are an integral part of theperi-operative patient management for any surgery. Even though there is enough literature on this topic, there still exists several grey areas and lacunae, which can give fodder to future research. The most compelling debate involves the choice of fluids for various surgeries and the patient population. The eternal controversy between the crystalloids and the colloids for peri-operative fluid management continues. The associated co-morbid conditions, the presence of hepatic, renal or cardiac dysfunction and the intra-operative turn of events can dictate the choice of fluids. The amount of fluids to be administered also vary in the pre-, intra-, and post-operative period for every patient. Excessive fluid administration can be as dangerous as under-therapy in the peri-operative setting and achieving a fine, working-balance between the two is an art. Judicious fluid therapy can prevent the development various complications like electrolyte imbalances, acid-base disorders, cardiac failure, renal shut-down, pulmonary oedema, cerebral oedema, liver dysfunction and myocardial ischemia. Some of these fluids themselves can cause adverse reactions like allergies, anaphylaxis, coagulation abnormalities, renal failure, hyperglycaemia and hyperviscocity. These have a direct impact on perioperative patient morbidity and mortality as well as economic implications. In addition, special considerations need to be given for fluid management in the paediatric and geriatric population. Needless to emphasize, peri-operative fluid therapy in a pregnant woman deserves special mention. This special issue is aimed at addressing these concerns and filling the gaps in our understanding of peri-operative fluid management.
Dr. Rakesh Garg